Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF)
<p>Abstract</p> <p>We have investigated the role of erythroid transcription factors mRNA expression in patients with acute myeloid leukemia (AML) in the context of cytogenetic and other prognostic molecular markers, such as FMS-like Tyrosine Kinase 3 (FLT3), Nucleophosmin 1 (NPM1),...
Main Authors: | Ayala Rosa, Martínez-López Joaquin, Gilsanz Florinda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://www.cancerci.com/content/12/1/25 |
Similar Items
-
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
by: Pimjai Niparuck, et al.
Published: (2019-01-01) -
Clinical implications of recurrent gene mutations in acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-03-01) -
Analysis of NPM1 and FLT3 Mutations in Patients with Acute Myeloid Leukemia in Jeddah, Saudi Arabia: A Pilot Study
by: Raed Alserihi, et al.
Published: (2023-03-01) -
FMS-Like Tyrosine Kinase 3 ( FLT3 ) and Nucleophosmin 1 ( NPM1 ) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics
by: Narges Rezaei, et al.
Published: (2017-11-01) -
Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile
by: Maria Elena Cabrera, et al.
Published: (2023-01-01)